Breaks Categories: News

MondaySep 18, 2017 9:19 am

HempNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Subsidiary Completes China FDA Filing; Moves toward Launch of Hemp-Infused Skin Care Line

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX), through wholly-owned subsidiary CBD Biotechnology Co. Ltd., this morning announced that it has completed the record filing process with the China Food & Drug Administration (“CFDA”) for its first line of non-industrial hemp-infused skin care products. Following this milestone, the company expects to launch its ‘CBD Magic Hemp Series’ skin care line in the next couple of months, effectively positioning CBD Biotechnology as a leader in what the company has called “an untapped segment of China’s skin care industry.” "I am very pleased to announce the upcoming launch of CBD Biotechnology's non-industrial hemp-infused…

Continue Reading

FridaySep 15, 2017 2:01 pm

HempNewsBreaks – Organigram (TSX.V: OGI) (OTCQB: OGRMF) Signs MOU with Canadian Provincial Authority for Distribution of Cannabis to Adult Recreational Market

Organigram Holdings Inc. (TSX.V: OGI) (OTCQB: OGRMF), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, today announced it has entered into a memorandum of understanding (MOU) with the New Brunswick provincial authority for the distribution of marijuana to the adult-use recreational market. Through the MOU, New Brunswick secures a supply of at least five million grams of recreational marijuana per year from Organigram. In a news release, Organigram CEO Greg Engel said, “We applaud the New Brunswick government’s efforts to foster an innovative, forward-thinking economic climate that supports cannabis as a driver of growth for New…

Continue Reading

ThursdaySep 14, 2017 3:56 pm

HempNewsBreaks – PotNetwork Holding (POTN) Subsidiary Secures More Than $200,000 in Sales at Recent Trade Show

Diamond CBD Sales, a subsidiary of PotNetwork Holding, Inc. (OTC: POTN), attained more than $200,000 in sales at the Big Industry Trade Show in New York on August 10-11. An article further discussing this topic reads: “In addition to the $200,000 at the BIG Industry Trade Show, Diamond CBD also generated sales of more than $320,000 at the Market Week Event, held in Las Vegas. Late in July, the firm also recorded revenues of some $300,000 at the CHAMPS trade show in Las Vegas, PotNetwork Holding said.” To view the full article, visit: http://cnw.fm/f3UbT About PotNetwork Holding, Inc. PotNetwork Holding,…

Continue Reading

ThursdaySep 14, 2017 12:09 pm

HempNewsBreaks – Hemp, Inc. (HEMP) Names New Dean of Hemp University

Hemp, Inc. (OTC: HEMP) this morning said that Hemp University has appointed Dr. Robert Ian Bruck (double Ph.D.), Director and Founder of North Carolina State University's Environmental Technology Program (B.S.) as its new Dean. As Dean, Bruck will be responsible for the management and development of the education curriculum. Additionally, Bruck will be speaking at the upcoming Hemp University educational symposium on September 30. "This appointment, in particular, is truly a rare opportunity to be on the front lines of this industrial hemp revolution by helping students achieve their hemp cultivation goals and inspiring more farmers to produce this multi-faceted…

Continue Reading

WednesdaySep 13, 2017 2:15 pm

HempNewsBreaks – The Green Organic Dutchman Holdings Secures $20M Pre-IPO Financing Agreement

The Green Organic Dutchman Holdings Ltd. (“TGOD”) earlier this week announced a $20 million private placement with a syndicate led by PI Financial Corp., priced at C$1.65 per unit. Shares will have a six-month hold period from the day of the company’s initial public offering (IPO), which is anticipated in January of 2018. The medicinal cannabis producer said it plans to use the net proceeds to advance its facilities in Ontario and Quebec, as well as for working capital purposes. View the full press release at http://cnw.fm/WWP6b About The Green Organic Dutchman Ltd. The Green Organic Dutchman Ltd. grows high…

Continue Reading

WednesdaySep 13, 2017 2:14 pm

HempNewsBreaks – Future Farm Technologies Inc. (CSE: FFT) (OTCQB: FFRMF) Harvests First California Cannabis Crop

Future Farm Technologies Inc. (CSE: FFT) (OTCQB: FFRMF) recently announced the harvest of its first cannabis crop from its previously announced Riverside County, California, cultivation facility. The company is currently drying, curing, trimming and packaging the flower in preparation for sale and distribution to medical patients in California later this month. Future Farm estimates the harvest of approximately 90 pounds with a market value of $144,000-$180,000. A video of the cultivation facility, filmed in July, is also online and available for viewing. To view the full press release, visit http://cnw.fm/66Ajl About Future Farm Technologies Inc. Future Farm’s business model includes…

Continue Reading

WednesdaySep 13, 2017 9:22 am

HempNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Enters Letter of Intent with BlazeNow, Inc.

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc., has executed a Letter of Intent with BlazeNow, Inc., a majority owned subsidiary of MediaTechnics Corporation (OTC: MEDT). BlazeNow, once called the “Yelp” of the cannabis industry by NY Daily News, is an advertising and data collection platform focused on connecting cannabis-related businesses with patients and customers. “We are excited to lay the groundwork for what we believe will be a very productive business partnership with BlazeNow,” Vanessa Luna, COO of MoneyTrac Technology, stated in the news release. “The goals are…

Continue Reading

TuesdaySep 12, 2017 10:23 am

HempNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Records 76% YOY Increase in Revenues for FY2017

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced its financial results for the fiscal year ended May 31, 2017. Among the highlights, the company recorded a 76 percent increase in total operating revenues as compared to 2016. CIIX noted that both its investor relations business and its subscription business posted strong growth during the 12-month period, with revenues increasing by 130 percent and 57 percent, respectively. The company also provided an update on its outlook for fiscal year 2018. “Although the business of our Consumer Division is still in the early stages, the recently launched 'OptHemp' product line…

Continue Reading

TuesdaySep 12, 2017 9:54 am

HempNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Files Provisional Patent Covering Proprietary Biosynthesis Program

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its filing of a provisional patent application pertaining to the company’s biosynthesis program for the manufacture of cannabinoids that are identical to those found in nature. Per the news release, this patent application, once converted into an international Patent Cooperation Treaty (PCT) application and pursued in key jurisdictions around the world, will offer significant commercial protections for InMed’s promising E. coli-based expression system, which enables the manufacture of any of the 90+ cannabinoid compounds found in the cannabis plant. “This novel approach to the biosynthesis of…

Continue Reading

MondaySep 11, 2017 1:11 pm

HempNewsBreaks – Tetra Bio-Pharma (TSX.V: TBP) (OTCQB: TBPMF) Accelerates its Cannabis-based Clinical Research Program in the Veterinary Market

Tetra Bio-Pharma (TSX.V: TBP) (OTCQB: TBPMF), a biopharmaceutical leader in cannabinoid-based drug discovery and development, is adding international expert Dr. Louis-Philippe de Lorimier, a board certified veterinary oncologist, to its clinical advisory board for the veterinary market. In a news release, Dr. Guy Chamberland, chief scientific officer of Tetra Bio-Pharma, said, "We are leveraging our current R&D work in humans to accelerate the development of the first cannabinoid-based drug for pets in the cancer-associated supportive therapy market, including pain. This market is underserved and patients and their owner are waiting for alternatives that are safer, more tolerable and more efficacious.”…

Continue Reading